Cancer Control

Reducing #FinancialToxicity in cancer care is not just about the intervention, it’s about implementation. Across 8 sites, operational data helped identify barriers and guide adaptations for more sustainable financial navigation. #Oncology #HealthEquity #CancerCare

#CancerScreening has impact only when systems can deliver diagnosis, referral, and treatment—not just detection. This Perspective discusses why cancer screening in resource-limited settings must be adapted to local capacity to achieve real #CancerControl impact. #GlobalHealth

#Delirium in hospitalized cancer pts is a major risk signal. In 126 pts w/ incident delirium, ~16% died in-hospital—linked to longer delirium, sepsis, low albumin/BMI/platelets, ↑LDH, and pre-delirium benzos. An actionable cue for earlier intervention. #Oncology #CancerCare

Childhood cancer survivors often miss survivorship care. Barriers: low awareness/need, anxiety/trauma, cost/insurance gaps, access (time/travel/housing), under-resourced services, tough pediatric→adult transition. #ChildhoodCancer #Survivorship #HealthEquity

Single-centre (@PeterMacCC) real-world data on #BiliaryTractCancer: 1st line gem/cis+ICI yields outcomes comparable to pivotal trials. ECOG & albumin predict survival. HER2 amp = worse OS; dMMR & BRCA = trend toward improved OS. Study highlights importance of molecular profiling.

Optimistic bias related adherence of metastatic #BreastCancer patients to oral anticancer treatments: negative association between adherence rate and self-perception of treatment adherence. Personality matters: conscientiousness = risk awareness; extraversion = overconfidence.

Higher state/local social + public health spending = fewer poverty-linked cancers. Top-spending states saw ~8% lower incidence and ~9% lower mortality. Investing upstream can cut cancer burden and narrow inequities. #Oncology #PublicHealth #SDOH #CancerPrevention #HealthEquity

A cross-sectional survey of 198 #BreastCancer specialists across Europe reports a strong endorsement of shared decision-making, but patchy uptake. Female physicians favour participatory styles. Digital #DecisionAids still underused compared to paper ones. #Communication #Oncology

Comprehensive review published in Cancer Control synthesizing #ClinicalTrials data on #OncolyticViruses (OVs) spanning 2013-2024. Provides an in-depth examination of OVs, highlighting their advancement from investigational modalities to clinical implementation. #ImmunoOncology

BRCA1/2-mutant early #BreastCancer: review urges region-tailored testing in Latin America, MRI-first screening, and shared surgical decision making. Neo-adjuvant platinum can raise pCR, while adjuvant olaparib improves OS. #BRCA #TNBC #PARPi #Latam